Brian Elsbernd, Chief Compliance/Legal Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 29,332 shares at $16.24 ($476K) on 2022-11-11, disclosed to the SEC on 2022-11-15.
Open-market sale of $476k CPRX by Chief Compliance/Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.24 | 14,666 | $238K | 50.0% |
| 2 | $16.24 | 14,666 | $238K | 50.0% |
| Total | $16.24 avg | 29,332 | $476K | 100% |
| Filing → |
| CPRX | SELL | 2025-09-05 | $1.4M | — | Filing → |
| CPRX | SELL | 2025-03-05 | $2.9M | — | Filing → |
| CPRX | SELL | 2024-11-29 | $372K | — | Filing → |